Webflow Mobile App Launch
WebflowTM is a comprehensive customer support center which provides PCI clients real-time, 24/7 access to a wide range of reports and information regarding the...
Faslodex receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib
AstraZeneca announced that the US FDA has approved a new indication for Faslodex (fulvestrant), expanding the indication to include use with abemaciclib, a CDK4/6...
TRACON Pharmaceuticals Announces Positive Results from Phase 1 Trial of TRC102 and Fludara® in Patients with Advanced Hematologic Malignancy Published in Oncotarget
TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration...
Jardiance® reduced risk of cardiovascular death in adults with type 2 diabetes and peripheral artery disease
New data presented showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with...
Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases
Boehringer Ingelheim and MiNA Therapeutics (“MiNA”), a pioneer in RNA activation therapeutics, announced that they have signed a collaboration and licensing agreement focused on...
Median Technologies to present at Medidata NEXT Global 2017 to discuss how new technologies can optimize image management in clinical trials
Median Technologies, The Imaging Phenomics Company® (ALMDT:PA) is pleased to announce that James Golando, Chief of Operations at Median Technologies will present on “Optimizing...
Sandoz biosimilar Erelzi matches efficacy, safety profile of reference biologic in rheumatoid arthritis
Sandoz, a Novartis division and the global leader in biosimilars, announces results from the EQUIRA study. The phase III comparative safety and efficacy study...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...